Insurance · Founded 2000 · www.sbilife.co.in · BSE 540719 · NSE SBILIFE · ISIN INE123W01016
No Notes Added Yet
Business
SBI Life Insurance Company Ltd. is one of the leading private life insurers in India. The company's core business is to provide a range of individual and group insurance products, including protection, savings, retirement, and health solutions. It operates on a model of collecting premiums from policyholders, investing these funds primarily in debt and equity markets, and then paying out claims upon maturity or unforeseen events. The company generates revenue through investment income on its policyholder funds, underwriting profits (when claims and expenses are lower than premiums), and fee income, particularly from Unit-Linked Insurance Plans (ULIPs).
Revenue Mix
SBI Life's product portfolio is broadly segmented into Individual (which includes participating, non-participating, and unit-linked products) and Group insurance solutions.
Individual Business: Comprises a majority of the premium income, driven by products catering to protection, wealth creation, and retirement planning.
Group Business: Provides coverage to employer-employee groups and other affinity groups, focusing on credit life, term, and superannuation schemes.
The primary distribution channel is Bancassurance, leveraging the extensive network and customer base of its parent, State Bank of India (SBI). Other distribution channels include individual agents, corporate agents, brokers, and direct sales.
Industry
The Indian life insurance industry is highly regulated by IRDAI and is characterized by a mix of public sector players (like LIC) and a growing number of private insurers. Despite its size, India's insurance penetration remains relatively low compared to developed economies, indicating significant growth potential. SBI Life is one of the largest and most well-established private life insurers in India by market share (based on individual adjusted premium equivalent - APE). Its strong parentage through State Bank of India provides a distinct competitive advantage in terms of brand trust and distribution reach.
MOAT
SBI Life possesses several durable competitive advantages:
Brand Trust: Leveraging the highly trusted and widely recognized brand name of State Bank of India, which is crucial in a financial services product like insurance.
Bancassurance Network: Exclusive access to State Bank of India's vast network of branches and millions of customers across India, providing an unparalleled distribution reach and customer acquisition pipeline.
Scale: As one of the largest private insurers, it benefits from economies of scale in operations, investment management, and marketing.
Customer Base: Inherits a large, loyal customer base from its parent bank, facilitating cross-selling opportunities.
Growth Drivers
Low Insurance Penetration: India's under-penetrated insurance market offers substantial room for growth as economic development and financial literacy increase.
Rising Disposable Incomes: Growing middle-class population and increasing disposable incomes lead to higher demand for savings, protection, and retirement products.
Financialization of Savings: A shift from traditional physical assets to financial instruments encourages insurance product uptake.
Digital Adoption: Increasing digitalization of sales and service processes can enhance efficiency, reduce costs, and expand reach.
Parent Bank's Growth: Continued expansion and customer acquisition by State Bank of India directly benefit SBI Life's bancassurance channel.
Risks
Interest Rate Fluctuations: Changes in interest rates can impact investment income, product pricing, and profitability.
Regulatory Changes: Evolving regulations from IRDAI regarding product design, pricing, solvency margins, and distribution can affect business models and profitability.
Intense Competition: The presence of numerous public and private insurers leads to pricing pressure and challenges in market share retention.
Investment Market Volatility: As a significant portion of assets is invested in capital markets, market downturns can impact investment returns and asset values.
Underwriting and Mortality Risk: Higher-than-expected claims due to adverse mortality/morbidity experience can impact profitability.
Economic Slowdown: A prolonged economic downturn can reduce disposable incomes, affecting new business premiums and persistency.
Management & Ownership
SBI Life is promoted by State Bank of India (SBI), which holds a majority stake. BNP Paribas Cardif is also a significant shareholder and a long-standing joint venture partner, bringing global expertise. The management team typically comprises experienced professionals from the insurance and financial services sector, benefiting from the strong governance framework and professional culture associated with SBI. The company is publicly listed, with a portion of shares held by institutional investors and the general public.
Outlook
SBI Life is well-positioned to capitalize on India's long-term insurance growth story, driven by its robust distribution network through SBI, strong brand recall, and diversified product portfolio. The potential for increasing insurance penetration, coupled with India's favorable demographics and rising incomes, provides a significant tailwind. However, the company operates in a competitive and highly regulated environment, subject to interest rate volatility and potential changes in economic conditions. Maintaining persistency, managing expense ratios, and innovating products will be crucial for sustained profitable growth amidst competitive pressures and evolving customer needs.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 22316 | 25116 | 15105 | 20266 | 24828 | 23861 | 17179 | 24848 | 30245 | 27684 |
| Other Income | 16734 | 12778 | 19551 | 20032 | -5968 | 560 | 21810 | -1717 | 15914 | -21700 |
| Total Income | 39051 | 37895 | 34657 | 40298 | 18859 | 24421 | 38989 | 23132 | 46159 | 5984 |
| Total Expenditure | 38681 | 37043 | 34060 | 39696 | 18266 | 23520 | 38333 | 22600 | 45517 | 5117 |
| Operating Profit | 370 | 851 | 597 | 601 | 594 | 901 | 656 | 532 | 642 | 867 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 370 | 851 | 597 | 601 | 594 | 901 | 656 | 532 | 642 | 867 |
| Provision for Tax | 48 | 40 | 77 | 72 | 43 | 87 | 62 | 37 | 65 | 62 |
| Profit After Tax | 322 | 811 | 520 | 529 | 551 | 814 | 594 | 495 | 577 | 805 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 322 | 811 | 520 | 529 | 551 | 814 | 594 | 495 | 577 | 805 |
| Adjusted Earnings Per Share | 3.2 | 8.1 | 5.2 | 5.3 | 5.5 | 8.1 | 5.9 | 4.9 | 5.8 | 8 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 15665 | 20852 | 25160 | 32890 | 40324 | 49768 | 58432 | 66581 | 80587 | 84060 | 99956 | 99956 |
| Other Income | 3454 | 9424 | 8600 | 11371 | 3519 | 32317 | 24595 | 15017 | 52044 | 33059 | 11145 | 14307 |
| Total Income | 19119 | 30276 | 33761 | 44261 | 43843 | 82085 | 83027 | 81598 | 132631 | 117119 | 111101 | 114264 |
| Total Expenditure | 18301 | 29442 | 32500 | 42906 | 41571 | 80180 | 81017 | 78595 | 129704 | 113926 | 109517 | 111567 |
| Operating Profit | 818 | 834 | 1261 | 1355 | 2271 | 1905 | 2010 | 3004 | 2927 | 3192 | 1584 | 2697 |
| Interest | 5 | 5 | 6 | 8 | 8 | 8 | 10 | 10 | 9 | 11 | 11 | 0 |
| Depreciation | 14 | 47 | 59 | 91 | 89 | 99 | 75 | 68 | 76 | 84 | 115 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 874 | 975 | 1184 | 1373 | 1414 | 1542 | 1561 | 1758 | 1942 | 2495 | 2537 | 2697 |
| Provision for Tax | 13 | 20 | 34 | 46 | -9 | 87 | 55 | 38 | 48 | 81 | 67 | 226 |
| Profit After Tax | 861 | 955 | 1150 | 1327 | 1422 | 1456 | 1506 | 1721 | 1894 | 2413 | 2470 | 2471 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 861 | 955 | 1150 | 1327 | 1422 | 1456 | 1506 | 1721 | 1894 | 2413 | 2470 | 2471 |
| Adjusted Earnings Per Share | 8.6 | 9.5 | 11.5 | 13.3 | 14.2 | 14.6 | 15.1 | 17.2 | 18.9 | 24.1 | 24.6 | 24.6 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 19% | 15% | 15% | 20% |
| Operating Profit CAGR | -50% | -19% | -4% | 7% |
| PAT CAGR | 2% | 13% | 11% | 11% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -3% | 11% | 12% | NA% |
| ROE Average | 14% | 14% | 14% | 16% |
| ROCE Average | 14% | 15% | 15% | 17% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 4691 | 5465 | 6374 | 7460 | 8884 | 10093 | 11418 | 12925 | 14592 | 16793 | 19087 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 76768 | 94742 | 113074 | 137155 | 155483 | 214731 | 259154 | 299053 | 380769 | 437013 | 476229 |
| Total Current Liabilities | 2503 | 2764 | 3216 | 3377 | 2784 | 3805 | 4559 | 4644 | 5195 | 5791 | 7508 |
| Total Liabilities | 83961 | 102971 | 122665 | 147992 | 167150 | 228629 | 275131 | 316622 | 400556 | 459597 | 502824 |
| Fixed Assets | 301 | 507 | 511 | 563 | 568 | 564 | 524 | 520 | 551 | 580 | 647 |
| Other Non-Current Assets | 78112 | 96040 | 114677 | 139529 | 159191 | 219116 | 265197 | 304724 | 385985 | 447959 | 487014 |
| Total Current Assets | 5548 | 6424 | 7476 | 7900 | 7391 | 8949 | 9410 | 11377 | 14020 | 11058 | 15163 |
| Total Assets | 83961 | 102971 | 122665 | 147992 | 167150 | 228629 | 275131 | 316622 | 400556 | 459597 | 502824 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 5378 | 3808 | 3141 | 4405 | 4084 | 6198 | 10875 | 10885 | 8923 | 6596 | 10139 |
| Cash Flow from Operating Activities | 5778 | 8525 | 10395 | 13473 | 19299 | 23878 | 21852 | 28656 | 29122 | 25547 | 34523 |
| Cash Flow from Investing Activities | -7204 | -9031 | -8910 | -13553 | -16987 | -19203 | -21611 | -30203 | -31221 | -21789 | -35318 |
| Cash Flow from Financing Activities | -144 | -144 | -221 | -241 | -198 | 3 | -231 | -415 | -227 | -215 | -179 |
| Net Cash Inflow / Outflow | -1570 | -651 | 1264 | -321 | 2113 | 4678 | 10 | -1962 | -2327 | 3543 | -974 |
| Closing Cash & Cash Equivalent | 3808 | 3157 | 4405 | 4084 | 6198 | 10875 | 10885 | 8923 | 6596 | 10139 | 9165 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 8.61 | 9.55 | 11.5 | 13.27 | 14.22 | 14.56 | 15.05 | 17.19 | 18.91 | 24.08 | 24.63 |
| CEPS(Rs) | 8.61 | 9.55 | 11.5 | 13.27 | 14.22 | 14.56 | 15.05 | 17.19 | 18.91 | 24.08 | 24.63 |
| DPS(Rs) | 1.5 | 1.5 | 2 | 2 | 0 | 2.5 | 2 | 2.5 | 2.7 | 2.7 | 2.7 |
| Book NAV/Share(Rs) | 46.91 | 54.65 | 63.74 | 74.6 | 88.84 | 100.92 | 114.13 | 129.11 | 145.68 | 167.53 | 190.21 |
| Core EBITDA Margin(%) | -16.83 | -41.19 | -29.17 | -30.45 | -3.09 | -61.11 | -38.65 | -18.04 | -60.95 | -35.53 | -9.57 |
| EBIT Margin(%) | 5.58 | 4.67 | 4.71 | 4.17 | 3.51 | 3.1 | 2.67 | 2.64 | 2.41 | 2.97 | 2.54 |
| Pre Tax Margin(%) | 5.58 | 4.67 | 4.71 | 4.17 | 3.51 | 3.1 | 2.67 | 2.64 | 2.41 | 2.97 | 2.54 |
| PAT Margin (%) | 5.5 | 4.58 | 4.57 | 4.03 | 3.53 | 2.93 | 2.58 | 2.58 | 2.35 | 2.87 | 2.47 |
| Cash Profit Margin (%) | 5.5 | 4.58 | 4.57 | 4.03 | 3.53 | 2.93 | 2.58 | 2.58 | 2.35 | 2.87 | 2.47 |
| ROA(%) | 1.13 | 1.06 | 1.06 | 1.02 | 0.93 | 0.76 | 0.61 | 0.6 | 0.54 | 0.57 | 0.52 |
| ROE(%) | 19.87 | 18.8 | 19.43 | 19.18 | 17.4 | 15.34 | 14 | 14.14 | 13.77 | 15.38 | 13.77 |
| ROCE(%) | 20.17 | 19.19 | 20.01 | 19.85 | 17.3 | 16.26 | 14.51 | 14.45 | 14.12 | 15.9 | 14.15 |
| Receivable days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Payable days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PER(x) | 0 | 0 | 58.54 | 43.68 | 45.07 | 60.48 | 74.41 | 63.97 | 79.21 | 64.28 | 72.18 |
| Price/Book(x) | 0 | 0 | 10.56 | 7.77 | 7.22 | 8.73 | 9.82 | 8.52 | 10.28 | 9.24 | 9.35 |
| Dividend Yield(%) | 0 | 0 | 0.3 | 0.35 | 0 | 0.28 | 0.18 | 0.23 | 0.18 | 0.17 | 0.15 |
| EV/Net Sales(x) | -0.1 | -0.07 | 2.57 | 1.69 | 1.55 | 1.71 | 1.86 | 1.59 | 1.8 | 1.82 | 1.75 |
| EV/Core EBITDA(x) | -1.98 | -1.71 | 51.31 | 40.97 | 27.59 | 44.8 | 54.16 | 35.26 | 49.63 | 48.02 | 110.56 |
| Net Sales Growth(%) | 22.58 | 33.11 | 20.66 | 30.72 | 22.6 | 23.42 | 17.41 | 13.95 | 21.04 | 4.31 | 18.91 |
| EBIT Growth(%) | 4.71 | 11.53 | 21.54 | 15.91 | 2.96 | 9.12 | 1.19 | 12.67 | 10.44 | 28.45 | 1.71 |
| PAT Growth(%) | 5 | 10.87 | 20.5 | 15.33 | 7.19 | 2.37 | 3.44 | 14.25 | 10.07 | 27.43 | 2.36 |
| EPS Growth(%) | 5 | 10.87 | 20.5 | 15.33 | 7.19 | 2.36 | 3.41 | 14.19 | 10 | 27.35 | 2.26 |
| Debt/Equity(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio(x) | 1.71 | 1.72 | 1.66 | 1.58 | 1.61 | 1.48 | 1.36 | 1.62 | 1.8 | 1.27 | 1.41 |
| Quick Ratio(x) | 1.71 | 1.72 | 1.66 | 1.58 | 1.61 | 1.48 | 1.36 | 1.62 | 1.8 | 1.27 | 1.41 |
| Interest Cover(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 55.43 | 55.42 | 55.41 | 55.39 | 55.38 | 55.38 | 55.37 | 55.36 | 55.34 | 55.33 |
| FII | 25.92 | 25.16 | 24.71 | 25.19 | 22.48 | 21.88 | 22.34 | 21.85 | 21.88 | 21.51 |
| DII | 14.63 | 15.41 | 15.89 | 15.32 | 17.92 | 18.68 | 18.24 | 18.7 | 18.72 | 19.13 |
| Public | 4.02 | 4.01 | 3.99 | 4.1 | 4.22 | 4.06 | 4.05 | 4.1 | 4.05 | 4.03 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 55.5 | 55.5 | 55.5 | 55.5 | 55.5 | 55.5 | 55.5 | 55.5 | 55.5 | 55.5 |
| FII | 25.96 | 25.19 | 24.75 | 25.24 | 22.53 | 21.93 | 22.39 | 21.9 | 21.94 | 21.58 |
| DII | 14.65 | 15.43 | 15.91 | 15.35 | 17.96 | 18.71 | 18.28 | 18.74 | 18.78 | 19.19 |
| Public | 4.02 | 4.02 | 4 | 4.11 | 4.23 | 4.07 | 4.06 | 4.11 | 4.06 | 4.04 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100.12 | 100.15 | 100.16 | 100.19 | 100.21 | 100.21 | 100.24 | 100.26 | 100.28 | 100.31 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +19% | +15% | +15% | +20% |
| Operating Profit CAGR | -50% | -19% | -4% | +7% |
| PAT CAGR | +2% | +13% | +11% | +11% |
| Share Price CAGR | -3% | +11% | +12% | — |
| ROE Average | +14% | +14% | +14% | +16% |
| ROCE Average | +14% | +15% | +15% | +17% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 55.43 | 55.42 | 55.41 | 55.39 | 55.38 | 55.38 | 55.37 | 55.36 | 55.34 | 55.33 |
| FII | 25.92 | 25.16 | 24.71 | 25.19 | 22.48 | 21.88 | 22.34 | 21.85 | 21.88 | 21.51 |
| DII | 14.63 | 15.41 | 15.89 | 15.32 | 17.92 | 18.68 | 18.24 | 18.7 | 18.72 | 19.13 |
| Public | 44.57 | 44.58 | 44.59 | 44.61 | 44.62 | 44.62 | 44.63 | 44.64 | 44.66 | 44.67 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 55.5 | 55.5 | 55.5 | 55.5 | 55.5 | 55.5 | 55.5 | 55.5 | 55.5 | 55.5 |
| FII | 25.96 | 25.19 | 24.75 | 25.24 | 22.53 | 21.93 | 22.39 | 21.9 | 21.94 | 21.58 |
| DII | 14.65 | 15.43 | 15.91 | 15.35 | 17.96 | 18.71 | 18.28 | 18.74 | 18.78 | 19.19 |
| Public | 44.62 | 44.65 | 44.66 | 44.69 | 44.71 | 44.71 | 44.74 | 44.76 | 44.78 | 44.81 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100.12 | 100.15 | 100.16 | 100.19 | 100.21 | 100.21 | 100.24 | 100.26 | 100.28 | 100.31 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.